About this trial
This research addresses obstructive sleep apnea syndrome (OSAS), affecting 6-12% of French adults, often treated with mandibular advancement devices (MADs). MADs may lead to occlusal modifications, causing a 50% treatment abandonment rate. The study employs surface electromyography to assess masticatory muscle activity before and during MAD use, correlating it with occlusal changes after 6 months. The primary goal is to determine dental displacement profiles post-6-month MAD treatment, providing insights for personalized care and minimizing treatment failures.
Eligibility criteria
Qualifiers
Patient with complete dentition (up to second molars)
Polysomnography or polygraphy
Diagnosis of OSA
Patient receiving OAM treatment at the Odontology Department of Toulouse University Hospital
Disqualifiers
Inability to provide informed consent
Pregnant or breastfeeding patient
Patient with curators, guardians, or legal protection
Trial design
Treatments tested in this trial
- Mandibular Advancement Device